GM-CSF regulates ILC states and myeloid cell signaling during ulceration in Crohns disease

This study demonstrates that GM-CSF acts as a critical spatial regulator in Crohn's disease by mediating myeloid-lymphoid crosstalk to restrain ILC1 expansion, sustain ILC3 maintenance, and promote IL-22 production, thereby limiting epithelial injury and inflammation in ulcerated intestinal regions.

The Gist

Imagine your gut is a bustling, busy city. Under normal conditions, the city runs smoothly: the streets are clean, the buildings (your cells) are well-maintained, and the police force (your immune system) is on standby but not causing a ruckus.

In Crohn's Disease, this city is under attack. The streets are torn up, buildings are crumbling (ulcers), and the police are panicking, causing more damage than the original attackers.

This paper is like a detective story that solves a mystery about a specific type of "peacekeeper" in this gut city called GM-CSF. For a long time, scientists were confused about whether this peacekeeper was a hero or a villain. Some thought it made the riot worse; others thought it helped.

Here is what the researchers discovered, broken down into simple concepts:

1. The Three "Growth Factor" Police Chiefs

The gut has three main commanders that tell immune cells what to do:

• M-CSF: The "Maintenance Chief." It's always there, keeping the regular police force (macrophages) fed and ready. It's like the city's daily sanitation crew.
• G-CSF: The "Emergency Response Chief." It shows up mostly at the borders (blood vessels) to call in reinforcements (neutrophils) when things get scary.
• GM-CSF: The "Special Ops Commander." This is the one the study focuses on. In a healthy city, it's barely used. But in a riot (Crohn's inflammation), it shows up specifically in the worst-hit areas (the ulcers).

2. The Map of the Riot (Spatial Transcriptomics)

The researchers used a high-tech camera (called Xenium) that can take a picture of the gut and see exactly which cell is saying what word.

They found something surprising:

• M-CSF and G-CSF were everywhere or just at the borders.
• GM-CSF was hiding in the granulation tissue—the "construction zone" where the body is trying to rebuild the broken streets. It wasn't in the middle of the burning building (the ulcer exudate); it was in the repair zone.

This suggested GM-CSF wasn't starting the fire; it was trying to put it out and rebuild.

3. The Zebrafish "Mini-City" Experiment

To test this, the scientists couldn't just experiment on humans. So, they used zebrafish larvae.

• Why zebrafish? They are tiny, transparent (you can see inside them!), and their immune systems work very similarly to humans, but they don't have "adaptive" immunity (the part that remembers past infections). This lets scientists study the "first responders" (innate immunity) in isolation.
• The Experiment: They created zebrafish that were missing the "receiver" for GM-CSF (like a radio with no antenna). Then, they gave all the fish a chemical that causes a gut riot (DSS).
• The Result:
  • Normal Fish: When given GM-CSF, the riot calmed down, the gut healed, and the damage stopped.
  • Fish without the Receiver: Even if they were given GM-CSF, it did nothing. The gut stayed destroyed.
  • Conclusion: GM-CSF is a hero that stops the damage, but only if the body has the right "antenna" to hear it.

4. The "Shape-Shifting" Troops (Innate Lymphoid Cells)

The gut has special troops called ILCs (Innate Lymphoid Cells). Think of them as the city's versatile special forces.

• ILC3s (The Builders): These are the good guys. They fix the gut lining and make sure the walls stay strong.
• ILC1s (The Destroyers): These are the angry mob. They scream "Attack!" and cause inflammation.

In Crohn's Disease: The riot turns the "Builders" (ILC3s) into "Destroyers" (ILC1s). The city loses its repair crew and gains more angry mobs.

The GM-CSF Fix: The study found that GM-CSF acts like a calming voice.

• It stops the "Builders" from turning into "Destroyers."
• It keeps the "Builders" working on the repair job.
• It tells the "Destroyers" to stand down.

Without GM-CSF, the "Builders" panic and join the mob, making the gut worse. With GM-CSF, the balance is restored.

5. The Secret Signal (pSTAT5)

How does GM-CSF talk to the cells? It uses a specific signal called pSTAT5.
The researchers looked at the human gut tissue and saw that in the "repair zones" (granulation tissue), the cells were glowing with this specific signal. It was like seeing a green light saying, "We are in repair mode, not war mode."

The Big Takeaway

For years, doctors were worried that GM-CSF might be making Crohn's Disease worse, so they tried to block it with drugs. This paper suggests the opposite: GM-CSF is actually a protector.

It is a local peacekeeper that shows up exactly where the gut is broken. Its job is to:

1. Stop the immune cells from going crazy.
2. Keep the "repair crews" (ILC3s) working.
3. Help the gut heal itself.

In simple terms: If Crohn's Disease is a city riot, GM-CSF isn't the arsonist; it's the fire chief trying to put out the flames and rebuild the houses. The problem in some patients might be that their "radios" (receptors) are broken, so they can't hear the fire chief's instructions.

Technical Summary

1. Problem Statement

Colony-stimulating factors (CSFs)—specifically M-CSF, G-CSF, and GM-CSF—are critical regulators of myeloid cell function. While M-CSF and G-CSF are well-understood in steady-state myelopoiesis, the specific roles of GM-CSF (CSF2) during intestinal inflammation, particularly in Crohn's disease (CD), remain controversial.

• Genetic Context: Genome-wide association studies (GWAS) link CSF2RB (the GM-CSF receptor beta chain) to CD risk. Loss-of-function mutations or neutralizing autoantibodies against GM-CSF are associated with increased disease severity.
• Knowledge Gap: Previous studies present conflicting results regarding whether GM-CSF is pro-inflammatory or protective. Furthermore, standard single-cell RNA sequencing (scRNA-seq) lacks the spatial resolution required to map the specific "source-target" interactions of GM-CSF within the complex microenvironment of ulcerated intestinal tissue.
• Objective: To define the spatial distribution of GM-CSF in CD ulcers, identify its cellular sources and targets, and elucidate its functional impact on innate lymphoid cells (ILCs) and myeloid cells during intestinal injury.

2. Methodology

The study employed a multi-modal approach combining human spatial transcriptomics, functional zebrafish modeling, and cross-species transcriptomic analysis.

• Human Tissue Analysis (Spatial Transcriptomics):
  • Sample: Paired inflamed (ulcerated) and uninvolved ileal resection tissues from 10 CD patients.
  • Technology: 10x Genomics Xenium In Situ single-cell spatial transcriptomics.
  • Analysis: Used scanpy for clustering and stlearn for ligand-receptor interaction analysis (focusing on CSF1, CSF2, CSF3 and their receptors). Immunofluorescence (IF) was used to validate protein localization and phosphorylation states (pSTAT5, pSTAT3, pERK).
• In Vivo Functional Model (Zebrafish):
  • Genetic Engineering: Generated a novel csf2rb knockout zebrafish line (csf2rb^mss15) using CRISPR-Cas9, resulting in a frameshift mutation and early stop codon.
  • Injury Model: Induced intestinal inflammation using Dextran Sodium Sulfate (DSS) in larval zebrafish.
  • Intervention: Treated larvae with recombinant human GM-CSF (rhGM-CSF) during active injury and recovery phases.
  • Readouts: Gut length, neutral red uptake (epithelial function), and RNAscope in situ hybridization for cytokine expression.
• Single-Cell RNA Sequencing (scRNA-seq):
  • Isolated Lck-GFP+ lymphocytes from larval zebrafish intestines.
  • Performed 10x Genomics scRNA-seq to characterize ILC populations (ILC1, ILC3, and proliferative ILCs) under control, DSS, and DSS+GM-CSF conditions.
  • Cross-Species Integration: Compared zebrafish ILC signatures with human ileal and rectal scRNA-seq datasets to identify conserved markers and transcriptional regulators.
  • RNA Velocity: Used scVelo to model transcriptional dynamics and cell state transitions (progenitor vs. differentiated).

3. Key Contributions

• Spatial Resolution of GM-CSF Niches: First to map GM-CSF expression specifically to ulcer granulation tissue (tissue repair zones) rather than the ulcer exudate (inflammatory debris), distinguishing it from M-CSF (ubiquitous) and G-CSF (endothelial).
• Mechanistic Insight into ILC Regulation: Demonstrated that GM-CSF signaling is critical for maintaining the balance between pro-inflammatory ILC1s and tissue-repairing ILC3s, preventing the pathological expansion of ILC1s seen in CD.
• Validation of Zebrafish as a Model: Established the larval zebrafish csf2rb^-/- model as a robust system for studying innate immune crosstalk (myeloid-ILC) independent of adaptive immunity, showing conserved GM-CSF signaling via STAT5.
• Resolution of Controversy: Provided evidence that GM-CSF acts as a protective, anti-inflammatory regulator in the context of intestinal ulceration by restraining ILC1 expansion and promoting ILC3-mediated repair (IL-22).

4. Key Results

A. Spatial Transcriptomics in Human CD Tissue

• Expression Patterns: M-CSF was highly expressed in stromal/mast cells; G-CSF in endothelial cells. GM-CSF was uniquely enriched in inflamed regions, specifically within ulcer granulation tissue.
• Cellular Sources: GM-CSF was primarily produced by lymphocytes (T cells/ILCs) in inflamed tissue.
• Receptor Targeting: The GM-CSF receptor alpha chain (CSF2RA) was restricted to monocytes/macrophages and dendritic cells, identifying them as the primary targets.
• Signaling: Spatial analysis revealed a significant increase in GM-CSF ligand-receptor interaction spots in inflamed tissue. Immunostaining confirmed that pSTAT5 (the downstream signal of GM-CSF) colocalized with GM-CSF and CD14+ macrophage aggregates in granulation tissue, whereas pSTAT3 and pERK did not show this specific correlation.

B. Functional Validation in Zebrafish

• Protective Role: Treatment with rhGM-CSF significantly reduced DSS-induced intestinal injury (rescued gut length and epithelial function) in Wild-Type (WT) zebrafish.
• Receptor Dependence: The protective effect of GM-CSF was completely abolished in csf2rb^-/- zebrafish, confirming the mechanism is receptor-dependent.
• Cytokine Modulation: GM-CSF treatment blunted the DSS-induced upregulation of pro-inflammatory cytokines (tnfa, il1b, osm) in WT fish but had no effect in knockouts.
• Signaling Activation: Exogenous GM-CSF significantly increased pSTAT5 levels in the zebrafish gut.

C. Regulation of Innate Lymphoid Cells (ILCs)

• ILC Plasticity: DSS treatment caused a >2-fold expansion of ILC1s and a contraction of ILC3s. Co-treatment with GM-CSF rescued this imbalance, restoring ILC3 numbers and suppressing ILC1 expansion.
• Gene Signatures:
  • ILC1s: Characterized by stress genes (HSPs) and ifng. GM-CSF suppressed ifng and the ILC1 gene module.
  • ILC3s: Characterized by rorc, il23r, and il22. GM-CSF promoted il22 expression (critical for barrier repair).
  • Proliferative ILCs: Identified a progenitor-like population expressing hmgn2. DSS drove these cells toward an ILC1-like phenotype (loss of hmgn2 transcription). GM-CSF preserved the native proliferative state.
• Cross-Species Conservation: Zebrafish ILCs shared conserved transcriptional regulators (e.g., TCF7, RUNX3, ID2) and marker genes with human ILCs, validating the model's relevance.

5. Significance and Conclusion

This study redefines the role of GM-CSF in Crohn's disease from a potentially pro-inflammatory driver to a critical spatial regulator of immune homeostasis.

• Mechanism: GM-CSF, produced by lymphocytes in ulcer granulation tissue, signals through STAT5 in macrophage aggregates. This signaling axis prevents the pathological conversion of tissue-repairing ILC3s into inflammatory ILC1s and sustains the production of IL-22.
• Therapeutic Implication: The findings suggest that preserving or enhancing GM-CSF signaling (rather than blocking it, as some anti-GM-CSF therapies attempt) may be beneficial for maintaining mucosal integrity and promoting healing in CD patients, particularly those with CSF2RB loss-of-function variants.
• Methodological Advance: The integration of Xenium spatial transcriptomics with a functional csf2rb knockout zebrafish model provides a powerful framework for dissecting cytokine niches and innate immune crosstalk in inflammatory bowel disease.